UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
(Mark One)
|
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the fiscal year ended
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO |
Commission File Number
(Exact name of Registrant as specified in its charter)
|
|
|
|
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
|
|
|
|
(Address of principal executive offices) |
(Zip Code) |
Registrant’s telephone number, including area code: (
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
|
|
|
|
|
(Nasdaq Global Select Market) |
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐
Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes ☐
Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files).
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
|
Large accelerated filer |
|
☐ |
|
Accelerated filer |
|
☐ |
|
|
|
☒ |
|
Smaller reporting company |
|
|
|
|
|
|
|
Emerging growth company |
|
|
If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the Registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes
The aggregate market value of the voting and non-voting common equity held by non-affiliates of the Registrant, based on the closing price of the shares of common stock on The Nasdaq Global Select Market on December 31, 2020, was
The number of shares of the Registrant’s common stock outstanding as of September 1, 2021 was
DOCUMENTS INCORPORATED BY REFERENCE
TABLE OF CONTENTS
|
|
|
|
|
Page |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 1. |
|
|
|
2 |
|
Item 1A. |
|
|
|
6 |
|
Item 1B. |
|
|
|
21 |
|
Item 2. |
|
|
|
21 |
|
Item 3. |
|
|
|
21 |
|
Item 4. |
|
|
|
21 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 5. |
|
|
|
21 |
|
Item 6. |
|
|
|
22 |
|
Item 7. |
|
|
|
22 |
|
Item 7A. |
|
|
|
35 |
|
Item 8. |
|
|
|
36 |
|
Item 9. |
|
|
|
36 |
|
Item 9A. |
|
|
|
36 |
|
Item 9B. |
|
|
|
37 |
|
Item 9C. |
|
Disclosure Regarding Foreign Jurisdictions that Prevent Inspections. |
|
37 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 10. |
|
|
|
37 |
|
Item 11. |
|
|
|
37 |
|
Item 12. |
|
|
|
37 |
|
Item 13. |
|
|
|
38 |
|
Item 14. |
|
|
|
38 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 15. |
|
|
|
38 |
|
Item 16 |
|
|
|
41 |
|
|
|
|
|
|
|
|
|
38 |
||
|
|
|
42 |
||
|
|
|
F-1 |
||
|
|
|
|
||
Unless the context otherwise requires, “we,” “us,” “our,” the “Company,” “Great Elm,” “GEG” and terms of similar import refer to Great Elm Group, Inc. and/or its subsidiaries.
Cautionary Statement Regarding Forward-Looking Information
This report and certain information incorporated herein by reference contain forward-looking statements under the Private Securities Litigation Reform Act of 1995. Such statements often include words such as “may,” “will,” “should,” “believe,” “expect,” “seek,” “anticipate,” “intend,” “estimate,” “plan,” “target,” “project,” “forecast,” “envision” and other similar phrases. Although we believe the assumptions and expectations reflected in these forward-looking statements are reasonable, these assumptions and expectations may not prove to be correct, and we may not achieve the financial results or benefits anticipated. These forward-looking statements are not guarantees of actual results. Our actual results may differ materially from those suggested in the forward-looking statements. These forward-looking statements involve a number of risks and uncertainties, some of which are beyond our control, including, without limitation:
|
|
▪ |
the ability of Great Elm Capital Management, Inc. (GECM) to profitably manage Great Elm Capital Corp. (NASDAQ: GECC), a business development company (BDC) that we manage through our investment management business; |
|
|
▪ |
the dividend rate that GECC will pay; |
|
|
▪ |
the ability of GECM to profitably manage Great Elm SPAC Opportunity Fund, LLC (GESOF), a privately-held fund with a focus on investments in special purpose acquisition companies that we manage through our investment management business; |
|
|
▪ |
our ability to continue to develop and grow our durable medical equipment and investment management businesses; |
|
|
▪ |
our ability to raise capital to fund our business plan; |
|
|
▪ |
our ability to make acquisitions and manage any businesses we acquire; |
|
|
▪ |
conditions in the equity capital markets and debt capital markets as well as the economy generally; |
|
|
▪ |
our ability to maintain the security of electronic and other confidential information; |
|
|
▪ |
serious disruptions and catastrophic events, including the impact of the Coronavirus Disease 2019 (COVID‑19) pandemic on the global economy; |
|
|
▪ |
competition, mostly from larger, well-financed organizations (both domestic and foreign), including operating companies, global asset managers, investment banks, commercial banks, and private equity funds; |
|
|
▪ |
outcomes of litigation and proceedings and the availability of insurance, indemnification and other third-party coverage of any losses suffered in connection therewith; |
|
|
▪ |
maintaining our contractual arrangements and relationships with third parties; |
|
|
▪ |
our ability to attract, assimilate and retain key personnel; |
|
|
▪ |
compliance with laws, regulations and orders; |
|
|
▪ |
changes in laws and regulations governing our operations; and |
|
|
▪ |
other factors described under “Item 1A. Risk Factors” or as set forth from time to time in our Securities and Exchange Commission (SEC) filings. |